CANCER TREATMENT

Dec 26 2024HEALTH

Thinking Clearly After Cancer: What Affects Young Adults' Brains?

Imagine you're a young adult who just went through cancer treatment. You might expect to feel physically better, but what about your brain? A recent study explored how cancer impacts young adults' thinking skills. They used both self-reports and tests. The study wanted to find out two things: first,

reading time less than a minute
Dec 25 2024HEALTH

Dividing the Bladder Cancer Puzzle: Early Growth vs. Spread

Imagine you're looking at two types of bladder cancer under a microscope. At first glance, they might seem similar, like two plants growing close together. But doctors are trying to figure out how to tell them apart. One type, called "early papillary formation, " grows upward like a tiny stem. The o

reading time less than a minute
Dec 25 2024HEALTH

Testing Larotrectinib: A New Hope for NTRK-Linked Cancers

Scientists are exploring a drug called larotrectinib to fight tumors with a specific gene issue. This drug has shown promise against certain cancers linked to a gene called NTRK. But how well does it work against cancers where NTRK is overactive, not just fused? A new clinical trial is trying to fin

reading time less than a minute
Dec 25 2024HEALTH

Tiny Copper-Gold Nanodots: A New Hope in Cancer Treatment

Have you ever thought about how tiny particles could help fight cancer? Meet gold-infused copper nanodots, also known as Au-doped Cu1. 92S nanodots. These tiny powerhouses have a unique ability to absorb laser light and convert it into heat, which can kill cancer cells. But that's not all! They also

reading time less than a minute
Dec 22 2024HEALTH

Understanding Lung Cancer's Journey: The Protein That Helps It Spread

Have you ever thought about how lung cancer cells move around and invade other parts of the body? It turns out, there's a protein involved in this tricky process. This protein, called integrin α3β1, acts like a helper, making it easier for lung cancer cells to spread. When scientists reduced the amo

reading time less than a minute
Dec 20 2024HEALTH

Oil Droplet Taxis: A New Route for Oral Cancer Medicine

Pancreatic cancer, especially the type called pancreatic ductal adenocarcinoma (PDAC), is very dangerous. A medicine called paclitaxel, or PTX, is often given through a needle (intravenously) to treat this cancer. PTX can trigger a special type of cell death that helps the immune system fight cancer

reading time less than a minute
Dec 15 2024HEALTH

Unlocking the Power of Protein Interactions: New Drugs for Cancer

Proteins are like tiny workers in our bodies, and they often team up to get things done. These partnerships, called protein-protein interactions (PPIs), are crucial for many important jobs, like telling cells when to grow or fixing damaged DNA. When these interactions go wrong, they can cause diseas

reading time less than a minute
Dec 14 2024HEALTH

Fighting TNBC: A New Hope Called Compound 43

Breast cancer comes in many forms, and one of the toughest types is Triple-Negative Breast Cancer (TNBC). This type of cancer doesn't have the usual targets that treatments often go for, making it tricky to treat. Scientists have been trying something clever though. They've been using a method calle

reading time less than a minute
Dec 13 2024HEALTH

Battle with Insurance: A Cancer Patient's Struggle

Imagine being in the middle of chemotherapy and having to fight your insurance company to get the medicine you need. That's what happened to Arete Tsoukalas, a 26-year-old law student from Indiana. After being diagnosed with leukemia, she found out her insurance required a $13, 000 monthly copay for

reading time less than a minute
Dec 12 2024SCIENCE

Copper Nanozymes Starve Tumors and Trigger Cell Death

Lung cancer treatment faces two big hurdles: upsetting the tumor's environment and making sure it stays that way. Scientists tackled this by creating a special nanozyme called Cu2O@Au. It's like a tiny catalyst, breaking down glucose at the tumor site. This starves the tumor of energy and creates hy

reading time less than a minute